Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

Regulatory Adoption of AI, ML, Computational Modeling & Simulation in In-Silico Clinical Trials for Medical Devices: A Systematic Review.

PMID: 41055689 ·

A, r, i, n, d, a, m, , D, e, ;, , A, l, k, a, , L, o, h, a, n, i

RevistaTherapeutic innovation & regulatory science
Ano
PMID41055689

Resumo

This study explores the revolutionary potential of in-silico clinical trials (ISCTs) in medical device development, emphasizing the integration of computational modeling and simulation (CM&S), artificial intelligence (AI), and machine learning (ML). It evaluates regulatory advancements by the FDA, EMA, and PMDA, identifies barriers to global ISCTs adoption, and proposes strategies to enhance credibility, standardization, and ethical alignment. A systematic review following PRISMA 2020 guidelines

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑